Cargando…
Impact of timing of atrial fibrillation, CHA(2)DS(2)-VASc score and cancer therapeutics on mortality in oncology patients
OBJECTIVES: To investigate timing and age distribution of atrial fibrillation (AF) in selected oncology patients, and the impact of AF timing, CHA(2)DS(2)-VASc score and cancer therapeutics on mortality. METHODS: This is a retrospective cohort study of oncology patients referred to the cardio-oncolo...
Autores principales: | Hussain, Muzna, Misbah, Rabel, Donnellan, Eoin, Alkharabsheh, Saqer, Hou, Yuan, Cheng, Feixiong, Crookshanks, Michael, Watson, Chris J, Toth, Andrew J, Houghtaling, Penny, Moudgil, Rohit, Budd, G Thomas, Tang, W H Wilson, Kwon, Deborah H, Jaber, Wael, Griffin, Brian, Kanj, Mohamad, Collier, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692982/ https://www.ncbi.nlm.nih.gov/pubmed/33243931 http://dx.doi.org/10.1136/openhrt-2020-001412 |
Ejemplares similares
-
CHA(2)DS(2)-VASc score, left atrial size and atrial fibrillation as stroke risk factors in the Tromsø Study
por: Tiwari, Sweta, et al.
Publicado: (2016) -
Improving CHA(2)DS(2)-VASc stratification of non-fatal stroke and mortality risk using the Intermountain Mortality Risk Score among patients with atrial fibrillation
por: Graves, Kevin G, et al.
Publicado: (2018) -
Proposed A(2)C(2)S(2)-VASc score for predicting atrial fibrillation development in patients with atrial flutter
por: Chen, Yung-Lung, et al.
Publicado: (2021) -
Better prediction of stroke in atrial fibrillation with incorporation of cancer in CHA(2)DS(2)VASC score: CCHA(2)DS(2)VASC score
por: Bungo, Brandon, et al.
Publicado: (2022) -
Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials
por: Martin, Ruairidh I R, et al.
Publicado: (2014)